Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Williams

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
NIHR Open Research|November 10, 2025
BronchStop Study Protocol, Season 2Shaun O'Hagan, Steve Cunningham, Simon B Drysdale, et al.
Archives of Disease in Childhood|February 25, 2026
Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and ScotlandShaun O' Hagan, Thomas C Williams, Robin Marlow, et al.
The Lancet Regional Health. Europe|September 15, 2025
Real-world impact of nirsevimab immunisation against respiratory disease on emergency department attendances and admissions among infants: a multinational retrospective analysisAida Perramon-Malavez, Danilo Buonsenso, Rosa Morello, et al.
The Lancet. Infectious Diseases|December 1, 2025
Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case-control study and cohort analysisIsobel McLachlan, Chris Robertson, Kirsty E Morrison, et al.
Wellcome Open Research|February 11, 2025
Update to: Study Pre-protocol for "BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study"Thomas C Williams, Steve Cunningham, Simon B Drysdale, et al.
The Lancet. Infectious Diseases|January 12, 2023
National case series of group A streptococcus pleural empyema in children: clinical and microbiological featuresVictoria Holdstock, Jonathan Twynam-Perkins, Timothy Bradnock, et al.
The Lancet Regional Health. Europe|February 12, 2026
Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysisAida Perramon-Malavez, Antonio Chiaretti, Ermengol Coma, et al.
Archives of Disease in Childhood|January 16, 2021
Indirect effects of the COVID-19 pandemic on paediatric healthcare use and severe disease: a retrospective national cohort studyThomas C Williams, Clare MacRae, Olivia V Swann, et al.
The EMBO Journal|July 1, 2018
RNase H2, mutated in Aicardi-Goutières syndrome, promotes LINE-1 retrotranspositionMaria Benitez-Guijarro, Cesar Lopez-Ruiz, Žygimantė Tarnauskaitė, et al.
The Pediatric Infectious Disease Journal|May 13, 2025
National 10-year Cohort Study of Life-threatening Invasive Group A Streptococcal Infection in Children, 2013-2023Victoria Holdstock, Emily Heppenstall, Donna Corrigan, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
NIHR Open Research|November 10, 2025
BronchStop Study Protocol, Season 2Shaun O'Hagan, Steve Cunningham, Simon B Drysdale, et al.
Archives of Disease in Childhood|February 25, 2026
Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and ScotlandShaun O' Hagan, Thomas C Williams, Robin Marlow, et al.
The Lancet Regional Health. Europe|September 15, 2025
Real-world impact of nirsevimab immunisation against respiratory disease on emergency department attendances and admissions among infants: a multinational retrospective analysisAida Perramon-Malavez, Danilo Buonsenso, Rosa Morello, et al.
The Lancet. Infectious Diseases|December 1, 2025
Effectiveness of the maternal RSVpreF vaccine against severe disease in infants in Scotland, UK: a national, population-based case-control study and cohort analysisIsobel McLachlan, Chris Robertson, Kirsty E Morrison, et al.
Wellcome Open Research|February 11, 2025
Update to: Study Pre-protocol for "BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study"Thomas C Williams, Steve Cunningham, Simon B Drysdale, et al.
The Lancet. Infectious Diseases|January 12, 2023
National case series of group A streptococcus pleural empyema in children: clinical and microbiological featuresVictoria Holdstock, Jonathan Twynam-Perkins, Timothy Bradnock, et al.
The Lancet Regional Health. Europe|February 12, 2026
Real-world impact of nirsevimab immunisation and maternal RSV vaccination against respiratory disease on emergency department attendances and admissions: a multinational retrospective analysisAida Perramon-Malavez, Antonio Chiaretti, Ermengol Coma, et al.
Archives of Disease in Childhood|January 16, 2021
Indirect effects of the COVID-19 pandemic on paediatric healthcare use and severe disease: a retrospective national cohort studyThomas C Williams, Clare MacRae, Olivia V Swann, et al.
The EMBO Journal|July 1, 2018
RNase H2, mutated in Aicardi-Goutières syndrome, promotes LINE-1 retrotranspositionMaria Benitez-Guijarro, Cesar Lopez-Ruiz, Žygimantė Tarnauskaitė, et al.
The Pediatric Infectious Disease Journal|May 13, 2025
National 10-year Cohort Study of Life-threatening Invasive Group A Streptococcal Infection in Children, 2013-2023Victoria Holdstock, Emily Heppenstall, Donna Corrigan, et al.
Pageof 8